Article references (22 references )

  1. Kidney research UK. Kidney Health for All - 10th Anniversary of World Kidney Day. 2015. Accessed August 03 2017

  2. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of CKD to the global burden of major noncommunicable diseases. Kidney Int. 2011 Dec 2; 80(12):1258-70. PubMed | Google Scholar

  3. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B et al. CKD: global dimension and perspectives. Lancet. 2013 Jul 20; 382(9888):260-72. PubMed | Google Scholar

  4. Imran S, Sheikh A, Saeed Z, Khan SA, Malik AO, Patel J et al. Burden of CKD in an urban city of Pakistan, a cross-sectional study. J Pak Med Assoc. 2015 Apr 1; 65(4):366-9. PubMed | Google Scholar

  5. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU et al. CKD as a global public health problem: approaches and initiatives, a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007 Aug 1; 72(3):247-59. PubMed | Google Scholar

  6. Wetmore JB, Collins AJ. Meeting the world's need for maintenance dialysis. J Am Soc Nephrol. 2015 Nov; 26(11):2601-3. PubMed | Google Scholar

  7. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2003 Oct; 42(4 Suppl 3): S1-201. PubMed | Google Scholar

  8. Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi T, Fukuhara S et al. Association of mineral metabolism factors with all-cause and cardiovascular mortality in HD patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int. 2007 Jul 1; 11(3):340-8. PubMed | Google Scholar

  9. Gheun-Ho Kim, Bum Soon Choi, Dae Ryong Cha, Dong Hyun Chee, Eunah Hwang, Hyung Wook Kim et al. Serum calcium and phosphorus levels in patients undergoing maintenance HD: a multicentre study in Korea. Kidney Res Clin Pract. 2014 Mar 1; 33(1):52-7. PubMed| Google Scholar

  10. Khan DA, Khan FA, Saif I. Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi. J Pak Med Assoc. 2009 Feb; 59(2):64-7. PubMed | Google Scholar

  11. Lebner AC1, Beard KM, Soroka SD, Cournoyer SH, Da Roza GA, Geary DFet al. Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada. Nephrol Dial Transplant. 2010 Jul 28; 26(1):156-63. PubMed | Google Scholar

  12. Rivera F, Sánchez de la Nieta MD, Echarri R, Anaya S, Carreño A, Vozmediano MC et al. CA-P control in haemodialysis and K/DOQI guidelines. Nefrologia. 2006; 26(3):351-7. PubMed | Google Scholar

  13. Maudell F, Gorriz JL, Pallardo LM, Pons R, Santiago C. Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia: assessment of phosphorus and calcium metabolism and its clinical management in haemodialysis patients in the community of Valencia. J Nephrol. 2005 Nov-Dec; 18(6):739-48.

  14. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M. Magnitude and impact of abnormal mineral metabolism in HD patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004 Nov; 44(5 Suppl 2):34-8. Google Scholar

  15. Djukanovic L, Dimkovic N, Marinkovic J, Djuric Z, Knezevic V, Lazarevic T et al. Association between HD patient outcomes and compliance with KDOQI and KDIGO targets for mineral and bone metabolism. Nephron. 2016; 132(3):168-74. PubMed | Google Scholar

  16. Benabdellah N, Karimi I, Bentata Y, Yacoubi H, Haddiya I. Phospho-calcic status in chronic HD in Oriental Morocco: assessment of adherence to K/DOQI and KDIGO recommendations. Pan Afr Med J. 2013; 16: 23. PubMed | Google Scholar

  17. Bourguignon C, Dupuy AM, Coste T, Michel F, Cristol JP. Evaluation of NM-BAPTA method for plasma total calcium measurement on Cobas 8000®. Clin Biochem. 2014 May 1; 47(7-8):636-9. PubMed | Google Scholar

  18. Alan Wu. Tietz Clinical Guide to Laboratory Test. 2006. 4th Edition.

  19. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta. 1971 Jan 1; 31(1):87-96. PubMed | Google Scholar

  20. Tanaka H, Komaba H, Koizumi M, Kakuta T, Fukagawa M. Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism. Ther Apher Dial. 2011 Jun;15(Suppl 1):56-61. PubMed | Google Scholar

  21. Ho LT, Sprague SM. Renal osteodystrophy in chronic renal failure. Semin Nephrol. 2002 Nov 1; 22(6): 488-93. PubMed | Google Scholar

  22. Drüeke TB. The new kidney disease: improving global outcomes (KDIGO) for nephrology & therapeutics (MBD-CKD). Nephrologie & therapeutique. 2010;6(3): 149-50. PubMed | Google Scholar